Flaquer Antònia, Rospleszcz Susanne, Reischl Eva, Zeilinger Sonja, Prokisch Holger, Meitinger Thomas, Meisinger Christa, Peters Annette, Waldenberger Melanie, Grallert Harald, Strauch Konstantin
Institute of Medical Informatics, Biometry and Epidemiology, Chair of Genetic Epidemiology, Ludwig-Maximilians-Universität, Munich, Germany; Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
Research Unit of Molecular Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany; Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
PLoS One. 2015 May 6;10(5):e0126294. doi: 10.1371/journal.pone.0126294. eCollection 2015.
It has been suggested that mitochondrial dysfunction has an influence on lipid metabolism. The fact that mitochondrial defects can be accumulated over time as a normal part of aging may explain why cholesterol levels often are altered with age. To test the hypothesis whether mitochondrial variants are associated with lipid profile (total cholesterol, LDL, HDL, and triglycerides) we analyzed a total number of 978 mitochondrial single nucleotide polymorphisms (mtSNPs) in a sample of 2,815 individuals participating in the population-based KORA F4 study. To assess mtSNP association while taking the presence of heteroplasmy into account we used the raw signal intensity values measured on the microarray and applied linear regression. Ten mtSNPs (mt3285, mt3336, mt5285, mt6591, mt6671, mt9163, mt13855, mt13958, mt14000, and mt14580) were significantly associated with HDL cholesterol and one mtSNP (mt15074) with triglycerides levels. These results highlight the importance of the mitochondrial genome among the factors that contribute to the regulation of lipid levels. Focusing on mitochondrial variants may lead to further insights regarding the underlying physiological mechanisms, or even to the development of innovative treatments. Since this is the first mitochondrial genome-wide association analysis (mtGWAS) for lipid profile, further analyses are needed to follow up on the present findings.
有人提出线粒体功能障碍会对脂质代谢产生影响。线粒体缺陷可能会随着时间的推移作为衰老的正常组成部分而累积,这一事实或许可以解释为什么胆固醇水平常常会随着年龄的增长而改变。为了检验线粒体变异是否与血脂谱(总胆固醇、低密度脂蛋白、高密度脂蛋白和甘油三酯)相关的假设,我们在参与基于人群的KORA F4研究的2815名个体样本中,分析了总共978个线粒体单核苷酸多态性(mtSNP)。为了在考虑异质性存在的情况下评估mtSNP的关联性,我们使用了在微阵列上测量的原始信号强度值,并应用了线性回归。十个mtSNP(mt3285、mt3336、mt5285、mt6591、mt6671、mt9163、mt13855、mt13958、mt14000和mt14580)与高密度脂蛋白胆固醇显著相关,一个mtSNP(mt15074)与甘油三酯水平相关。这些结果突出了线粒体基因组在有助于调节脂质水平的因素中的重要性。关注线粒体变异可能会带来关于潜在生理机制的进一步见解,甚至可能促成创新治疗方法的开发。由于这是首次针对血脂谱的线粒体全基因组关联分析(mtGWAS),需要进一步分析来跟进目前的研究结果。